Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RO7830698 in Healthy Participants and Participants With COPD
NCT07822334Phase 2Recruiting
- Sponsor
- Roche
- Start
- Oct 2026
- Primary completion
- Oct 2028
- Countries
- 1
01
Overview
A Phase 2 trial of RO7830698 in chronic obstructive pulmonary disease (COPD), sponsored by Roche. Started Oct 2026; status: recruiting.
02
Drugs
RO7830698
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT07822334.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07822334.